![Rasmus Holm-Jorgensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rasmus Holm-Jorgensen
Keine laufenden Positionen mehr
Vermögen: 41 741 $ am 31.05.2026
Profil
Mr. Rasmus Holm-Jorgensen was previously employed as a Chief Financial Officer by Acrivon Therapeutics, Inc., a Chief Strategy & Portfolio Officer by Kiniksa Pharmaceuticals Ltd., and a Group Vice President & General Manager by Synageva BioPharma Corp.
He received his graduate degree from the University of Copenhagen.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2025 | 26’088 ( 0.06% ) | 41 741 $ | 31.05.2026 |
Ehemalige bekannte Positionen von Rasmus Holm-Jorgensen
| Unternehmen | Position | Ende |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.04.2025 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Gründer | 01.04.2022 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Rasmus Holm-Jorgensen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Wählen Sie MarketScreener 
